Twenty-four hour urine monocyte chemotactic protein-1 levels were comparable in all four groups but did show a decreasing trend in the losartan and combination regimen groups.
← all excerpts
Effects of spironolactone and losartan on diabetic nephropathy in a type 2 diabetic rat model.
1
—
—